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Introduction
cetaminophen (N-acetyl-paminophenol; APAP) is widely used as an analgesic and antipyretic drug worldwide. It produces alanine derivatives by hydrolysis, which are directly converted into hydroxylamine.
N-Acetyl-pbenzoquinoneimine (NAPQI) is an intermediate product of acetaminophen produced in the presence of cytochrome-p450 that causes hepatic damage both in humans and experimental animals (Soundharrajan et al., 2016) .
Caspase-cleaved cytokeratin 18 (CK18-Asp396) is released from hepatocytes during apoptosis. In apoptotic cell death, intermediate filament protein cytokeratin 18 (CK18) is cleaved by caspases at Asp396 and the product (M30 antigen) may be specifically detected by the monoclonal antibody M30. In this regard, a growing body of evidence clearly indicates that levels of CK18-Asp396 may be used as a surrogate biomarker of apoptotic cell death (Ueno et al., 2003andYagmur et al., 2007 .
As hepatic injury generally starts 24 to 72 hours after paracetamol ingestion with marked elevations in serum ALT and AST (http://livertox.nih.gov/Acetaminophen.ht m), the current study was conducted to investigate that Cytokeratin 18-Asp396 can represent an early and valuablepredictor of preclinical and clinical acute paracetamol-induced hepatotoxicity in human.
Subjects and Methods

Subjects
Our study involved 84 subjects of both sexes.
were determined by commercially available immunoassays (M30-Apoptosense ELISA kit, Peviva AB, Bromma, Sweden) according to the manufacturer's protocol. In brief, samples were placed into wells coated with a mouse monoclonal antibody as a catcher. After washing, a horseradish peroxidaseconjugated antibody (M30) was used for detection. Reference concentrations of CK18-Asp396 were used to prepare assay calibration.
The absorption was determined with an ELISA reader at 450 nm. Inter-and intra-assay coefficients of variation were below 10%. Concentrations of CK18-Asp396 were expressed in units per liter (U/l) according to the manufacturer's instructions. Plasma CK18-Asp396 levels within 20 normal healthy volunteers were assessed using the M30 Apoptosense ELISA. Within the population studied there was a wide range of values, from 57 to 862 U/l, with a mean of 121 + 46 U/l. This value was considered as the laboratory control which compared with the other results of the different post-ingestion periods. The values were independent of age and gender.
Statistical analysis
The collected data was organized, tabulated and statistically analyzed using SPSS software statistical computer package version 17. Data were expressed as Mean + Standard Deviation (SD). Paired sample-t test was used to differentiate between two means where probability (P); P < 0.05: was considered significant. Correlations were estimated using Pearson's test where probability (P): P < 0.05 was considered significant. Results Fromthe 127 adult patients with a history of paracetamol overdose and with a delay time not more than 4 hours, only 84 patients had been confirmed to have acute paracetamol toxicity according to Rumack-Mattew nomogram (Rumack and Mattew, 1975) . There was a wide range (157.12-313.27 µg/ml) with a mean + S.D of (187.47 +23.11µg/ml), which indicated the possibility of acute paracetamolinduced hepatotoxicity.
The results of the current study revealed that all investigated liver function tests including ALT, AST, ALP and bilirubin started to be increased with statistically significant values after 24 hours post-ingestion, reached a peak after 36 hours, and started to decline after 48 hours. On the other hand it has been found that Cytokeratin 18-Asp396 values were increased significantly 4 hours postingestion (765.38 + 122.14 U/l) when compared to mean values of healthy volunteers that was 121 + 46 U/l, reached a peak after 36 hours, and started to decline after 48 hours (Table 1 and Figs. 1, 2 & 3) . Table 2 shows ALT values (U/l) as mean+ S.D of acute paracetamol intoxicated patients at different hours post-ingestion. There was significant statistical elevation of ALT values at 24 hrs, 36 hrs and 48 hrs postingestion when compared to ALT value 4 hrs post-ingestion. Also, there was significant statistical elevation of ALT values at 36 hrs and 48 hrspost-ingestion when compared to ALT value 24 hrs post-ingestion. In addition, there was significant statistical elevation of ALT value 48 hrspost-ingestion when compared to ALT value 36 hrs post-ingestion. Table 3 shows AST values (U/l) as mean+ S.D of acute paracetamol intoxicated patients at different hours post ingestion. There was significant statistical elevation of AST values at 24hrs, 36 hrs and 48 hrs postingestion when compared to AST value 4 hrs post-ingestion. Also, there was significant statistical elevation of AST values at 36 hrs and 48 hrspost-ingestion when compared to AST value 24 hrs post-ingestion. In addition, there was significant statistical elevation of AST value 48 hrspost-ingestion when compared to AST value 36 hrs post-ingestion. Table 4 shows ALP values (U/l) as mean+ S.D of acute paracetamol intoxicated patients at different hours post-ingestion. There was significant statistical elevation of ALP values at 24hrs, 36 hrs and 48 hrs postingestion when compared to ALPvalue 4 hrs post-ingestion. Also, there was significant statistical elevation of ALP values at 36 hrs and 48 hrspost-ingestion when compared to ALPvalue 24 hrs post-ingestion. In addition, there was significant statistical elevation of ALP value 48 hrspost-ingestion when compared to ALPvalue 36 hrs postingestion.All of the above elevations were of statistical significance only because ALPvalues at different post-ingestion periods were in the normal laboratory range. 
Discussion
Paracetamol (acetaminophen) toxicity remains theleading cause of acute liver failure in the developed world, accounting for over 40% of cases inselected case series (Ostapowicz et al., 2002) . As the liver enzymatic changes don't take place in the first 24 hours after ingestion of paracetamol(livertox.nih.gov), their use in the early assessment of the liver state is not accurate. Moreover, the translational multimechanistic events of APAP liver toxicity are well described and can be monitored with circulating mechanism-based biomarkers in human and murine models (Antoine et al., 2012and Antoine et al., 2013 . Accordingly, the current study was conducted to investigate that Cytokeratin 18-Asp396can representan early and valuable predictor of pre-clinical and clinical acute paracetamol toxicity in humans.
The results of the current study revealed that all investigated liver function tests including ALT, AST, ALP and bilirubin started to be increased with statistically significant values after 24 hours post-ingestion, reached a peak after 36 hours, and started to decline after 48 hours. These findings are in accordance with many previous studies (Tsutsui et al., 2010andSoundharrajan et al., 2016 . Basing on these findings, it could be concluded that the use of liver enzymes, as routinely done, to assess the liver state in early APAP-induced hepatotoxicity is not accurate. This could be explained by the fact that the process of increasing liver enzymes is a timeconsuming process that becomes evident after the disruption of mass hepatocytes membranes (Amacher, 1989) .
On the other hand, it has been found that Cytokeratin 18-Asp396 values were increased significantly 4 hours post-ingestion, reached a peak after 36 hours, and started to decline after 48 hours. These findings are in agreement with Hofer et al., (2009) , who stated that Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction (http://ccforum.com/content/13/3/R93).
These findings could be explained by the well-established data that serum CK18-Asp396 levels have been associated with apoptotic activity as assessed by TUNEL (Duan et al., 2003) . After the initiation of apoptosis, CK18 is cleaved by caspases, releasing a neoepitope termed CK18-Asp396, which is specifically recognized by the M30 monoclonal antibody (Kramer et al., 2004) . The specific proteolytic cleavage of CK18 is an event which occurs before the disruption of membrane asymmetry (Caulin et al., 1997) .
Conclusion
In conclusion, Cytokeratin 18-Asp396may be used as an early and valuablepredictor of preclinical and clinical acute paracetamol toxicity in humans.To the best of our knowledge, this is the first report that the levels of apoptosisspecific epithelial cell-derived caspase-cleaved CK18 neoepitope, as detected by CK18-
